Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |
12/08/2010 | EP2258721A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
12/08/2010 | EP2258720A1 Multiple target T cell receptor |
12/08/2010 | EP2258719A1 Multiple target T cell receptor |
12/08/2010 | EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
12/08/2010 | EP2258715A1 Kahalalide compounds |
12/08/2010 | EP2258402A2 Dried composition |
12/08/2010 | EP2258397A1 Polymer conjugate of physiologically active substance |
12/08/2010 | EP2258383A2 Antigenic peptides derived from telomerase |
12/08/2010 | EP2258382A2 Amylin and amylin agonists for treating psychiatric diseases and disorders |
12/08/2010 | EP2258381A2 Ghrelin analogs |
12/08/2010 | EP2258379A1 Use of platelet rich plasma composition |
12/08/2010 | EP2258363A1 Compositions for treatment of cancers |
12/08/2010 | EP2258208A1 Protein Product With Modified Antigenicity |
12/08/2010 | EP2257570A2 Splice variants of gdnf and uses thereof |
12/08/2010 | EP2257569A1 Method of treatment using antimicrobial composition |
12/08/2010 | EP2257311A1 Conjugated factor viii molecules |
12/08/2010 | EP2257305A2 A novel pharmaceutical preparation for preeclampsia, eclampsia, and toxemia and their related symptoms and related disorders of pregnancy |
12/08/2010 | EP2257304A1 Sustained release poloxamer containing pharmaceutical compositions |
12/08/2010 | EP2257303A1 Uses of modified elr-cxc chemokine g31p |
12/08/2010 | EP2257287A2 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates |
12/08/2010 | EP2257270A1 Combination of a light ray with a cytochrome c oxydase substrate particularly for improving the appearance of the skin and/or hair |
12/08/2010 | EP2257185A1 Methods and compositions of sphingolipid for preventing and treating microbial infections |
12/08/2010 | EP2257163A2 Bone paste composition |
12/08/2010 | EP1917355B1 Ply-gbs mutant lysins |
12/08/2010 | EP1793844B1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection |
12/08/2010 | EP1735433B1 Subtilase variants having altered immunogenicity |
12/08/2010 | EP1729792B1 Y4 selective receptor agonist for therapeutic interventions |
12/08/2010 | EP1572726B1 4-methylhexanoic kahalalide f compound |
12/08/2010 | EP1551867B1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
12/08/2010 | EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents |
12/08/2010 | EP1494693B1 Cripto-specific antibodies |
12/08/2010 | EP1480674B1 Treatment of central nervous system damage |
12/08/2010 | EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
12/08/2010 | EP1438329B1 Biologically active peptides and their use for repairing injured nerves |
12/08/2010 | EP1427750B1 Modified transferrin fusion proteins |
12/08/2010 | EP1392717B1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
12/08/2010 | EP1270588B1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
12/08/2010 | EP1093457B1 Cytokine receptor common gamma chain like |
12/08/2010 | EP1082341B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
12/08/2010 | EP0916345B1 Human growth hormone for treating anorexia nervosa |
12/08/2010 | EP0826041B1 Transforming growth factor alpha hii |
12/08/2010 | CN1993113B Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof |
12/08/2010 | CN1968704B Topical cromolyn formulations |
12/08/2010 | CN1948333B New hPEBP4 protein source HLA-A2 limiting epi-polypeptide and its application |
12/08/2010 | CN1826170B Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation |
12/08/2010 | CN1803837B Neurotrophic growth factor |
12/08/2010 | CN1650005B Antimicrobial polypeptide and utizliation thereof |
12/08/2010 | CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
12/08/2010 | CN1537526B Method for delievering materials into skin and compositions used therein |
12/08/2010 | CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
12/08/2010 | CN1434681B Method for maintaining or improving the synthesis of mucins |
12/08/2010 | CN101909694A Treatment of premature birth complications |
12/08/2010 | CN101909645A Blood pressure lowering combination comprising IPP and/or VPP |
12/08/2010 | CN101909603A An orally-absorbed solid dose formulation for vancomycin |
12/08/2010 | CN101909599A Counter-pressure filtration of proteins |
12/08/2010 | CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same |
12/08/2010 | CN101906456A Preparation method and use of antioxidant peptide derived from mytilus coruscus |
12/08/2010 | CN101906455A Preparation method of egg white protein assistant antihypertensive peptides |
12/08/2010 | CN101906413A Heterologous expression of neisserial proteins |
12/08/2010 | CN101906158A Pegylation hypoglycemic polypeptide and preparation method and application thereof |
12/08/2010 | CN101906156A Structures and application of bifunctional protein and derivatives of bifunctional protein |
12/08/2010 | CN101906152A Stx2 inhibitor peptide and vero toxin-neutralizing agent |
12/08/2010 | CN101906149A Linear polypeptide and synthetic method and application thereof |
12/08/2010 | CN101906148A Survivin-derived peptides and use thereof |
12/08/2010 | CN101906147A Conjugate formed by two Arg-Gly-Asp-Ser chains and one fatty alcohol chain through Lys, synthesis thereof and application in medicine |
12/08/2010 | CN101906146A Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine |
12/08/2010 | CN101906145A Conjugate and a synthesis method of two Arg-Gly-Asp-Val chains and fatty alcohol chain through Lys, as well as application in medicine |
12/08/2010 | CN101906144A Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof |
12/08/2010 | CN101906143A Conjugate of two Arg-Gly-Asp chains and one fatty alcohol chain through Lys, synthesis and medicine application thereof |
12/08/2010 | CN101906142A Carboline carboxylic acid-tetrapeptide conjugate and synthesis method as well as medical application thereof |
12/08/2010 | CN101906141A Conjugates of one class of peptide chain and double fatty alcohol chains as well as preparation method and application thereof |
12/08/2010 | CN101906140A Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof |
12/08/2010 | CN101906139A Conjugate of peptide chain, Lys and aliphatic alcohol chain, preparation method and application thereof |
12/08/2010 | CN101906138A Pseudo cyclic polypeptide and synthesis method and application thereof |
12/08/2010 | CN101906137A Conjugate of Arg-Gly-Asp chain and two fatty alcohol chains, synthesis and medical application thereof |
12/08/2010 | CN101906136A Amino acid-(3,4-dyhydroxy-Phe)-Ser-Leu false peptide, and synthesizing method and application thereof |
12/08/2010 | CN101906135A Novel spirulina source antihypertensive peptide and preparation method thereof |
12/08/2010 | CN101906134A Peptidic compounds |
12/08/2010 | CN101906133A Preparation method and application of corn angiotensin converting enzyme inhibitory peptide |
12/08/2010 | CN101906097A 1,3-dioxane compounds as well as synthesizing method and medical application thereof |
12/08/2010 | CN101905033A Medicament microcapsule composite calcium deficiency calcium phosphate bone cement and use, preparation method and application thereof |
12/08/2010 | CN101905024A Composition comprising and method of using angiopoietin-like protein 3 ANGPTl3 |
12/08/2010 | CN101905023A Method of effectively using medicine and method concerning prevention of side effect |
12/08/2010 | CN101905017A Method for preparing chitosan nanoparticles |
12/08/2010 | CN101905016A Novel application of trefoil factor 3 |
12/08/2010 | CN101905015A Medicine capable of decomposing alcohol, preventing drunkenness and protecting liver |
12/08/2010 | CN101904846A Amlodipine nicotinate with synergetic blood pressure reducing function and treatment composition thereof with Benazapril medicament |
12/08/2010 | CN101314029B Acetylsalicylic peptide and preparation method thereof |
12/08/2010 | CN101288767B Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method |
12/08/2010 | CN101273057B Bone morphogenesis protein 2 active peptide and production method and application |
12/08/2010 | CN101248998B Vacuum hemostix |
12/08/2010 | CN101210050B Antibodies for preventing bloodvessel endothelium growth factor |
12/08/2010 | CN101180044B Combination of EGF/GHRP-6 for neuroregeneration of central nervous system |
12/08/2010 | CN101165070B A series of fusion protein with dual biological activity and medical treatment thereof |
12/08/2010 | CN101143892B Method for resolving enantiomer by enzyme catalysis |
12/08/2010 | CN101089019B Polypeptides with antithrombotic activity and their prepn process and application |
12/08/2010 | CN101077414B Medicine new use for liver hydrolysis-peptide |
12/08/2010 | CN101076353B Releasable polymer conjugate based on aliphatic biodegradable joint |
12/08/2010 | CN101062408B Oral insulin compound medicine preparation and its preparing method |